Stemtech (STEK) Net Cash Flow (2012 - 2025)
Stemtech's (STEK) quarterly Net Cash Flow came in at $196425.0 in Q4 2025, down 73.44% year-on-year from $739442.0 in Q4 2024, and up 243.82% quarter-over-quarter from -$136577.0 in Q3 2025.
Stemtech (STEK) Net Cash Flow (2012 - 2025) Analysis & Trends
Stemtech has disclosed Net Cash Flow across 14 years of filings, most recently posting $196425.0 for Q4 2025.
- Net Cash Flow for Q4 2025 came in at $196425.0, down 73.44% year-over-year; the trailing twelve-month figure through Dec 2025 was -$23573.0 (down 104.93% YoY), and the FY2025 annual result was -$23573.0, down 104.93% from the prior year.
- Net Cash Flow came in at $196425.0 for Q4 2025 at Stemtech, up from -$136577.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $2.0 million in Q3 2021 to a low of -$1.2 million in Q3 2024.
- The 5-year median for Net Cash Flow is -$97193.5 (2022), against an average of -$8290.6.
- Across the five-year window, Net Cash Flow slumped 544.88% in 2024 and surged 444.14% in 2025, its largest moves.
- Stemtech's Net Cash Flow stood at -$1.0 million in 2021, then surged by 59.34% to -$416761.0 in 2022, then tumbled by 106.64% to -$861191.0 in 2023, then soared by 185.86% to $739442.0 in 2024, then tumbled by 73.44% to $196425.0 in 2025.
- The last three Net Cash Flow figures came in at $196425.0 (Q4 2025), -$136577.0 (Q3 2025), and $548332.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 202.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -526.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -277.40 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -446.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -112.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -768.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -3.97 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 139.49 Mn |
| 10 | Stemtech | - | - | 354,677.00 | 196,425.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 196,425.00 |
| Dec 31, 2025 | 196,425.00 |
| Sep 30, 2025 | -136,577.00 |
| Sep 30, 2025 | -136,577.00 |
| Jun 30, 2025 | 548,332.00 |
| Jun 30, 2025 | 548,332.00 |
| Mar 31, 2025 | -631,753.00 |
| Mar 31, 2025 | -631,753.00 |
| Dec 31, 2024 | 739,442.00 |
| Dec 31, 2024 | 739,442.00 |
| Sep 30, 2024 | -1.17 Mn |
| Sep 30, 2024 | -1.17 Mn |
| Jun 30, 2024 | -159,334.00 |
| Jun 30, 2024 | -159,334.00 |
| Mar 31, 2024 | 1.07 Mn |
| Mar 31, 2024 | 1.07 Mn |
| Dec 31, 2023 | -861,191.00 |
| Dec 31, 2023 | -861,191.00 |
| Sep 30, 2023 | 263,308.00 |
| Sep 30, 2023 | 263,308.00 |